Norwegian Psychomotor Physiotherapy - The Effect on Quality of Life (NCT02282007) | Clinical Trial Compass
CompletedNot Applicable
Norwegian Psychomotor Physiotherapy - The Effect on Quality of Life
Norway105 participantsStarted 2014-02
Plain-language summary
More and more people suffer from stress-related illness and ailments that can greatly affect the individual's experienced quality of life and sense of coping since pain, physical, mental and social functioning are closely linked. Many of these people will seek primary care for help, and thus be referred to the Norwegian psychomotor physiotherapy (NPMP) performed by physiotherapists in primary care.
Data shows that for the first three months of 2009, 42% of patients were referred to NPMP had a musculoskeletal diagnosis as the first diagnosis, often in the form of long-term and comprehensive pain problems. Many of the patients also had emotional difficulties, but without being diagnosed with mental illness. 23% of patients who were referred to NPMP had a psychiatric diagnosis as the first diagnosis. The full range of psychiatric diagnoses are represented, but the majority of patients were treated for anxiety and depression.
The investigators want to let people who have had NPMP treatment to consider what effect the treatment has given, measured by separate registrations of quality of life, pain, physical, mental and social functioning.
Who can participate
Age range
18 Years – 90 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Being referred to NPMP
. Being able to give informed consent
. The therapist finds the NPMP to be a proper treatment to this patient
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial tested something called Norwegian Psychomotor Physiotherapy for conditions like chronic pain and psychosomatic disorders — is this type of therapy something that might be appropriate for my specific situation, and are there practitioners near me who offer it?
2The trial measured quality of life using a questionnaire called the SF-36 at 6 and 12 months — based on the results, did patients actually report meaningful improvements in how they felt day-to-day, and how long might it realistically take before I notice any difference?
3Since this study is now completed, have the findings been published, and can you help me understand whether the results showed enough benefit to consider this approach over other treatments I might already be eligible for?
4Norwegian Psychomotor Physiotherapy involves a fairly intensive, body-based approach to physical and emotional stress — given my current health and lifestyle, is the time commitment and hands-on nature of this type of therapy realistic for me to take on?
5Are there standard treatments for my pain or stress-related symptoms that I should try first before exploring a therapy like this, or could this work alongside what I'm already doing?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change from baseline in Short-form Health Survey (SF-36) at 6 months
Timeframe: 6 months
2
Change from baseline in Short-form Health Survey (SF-36) at 12 months